Thyroid hormone replacement therapy in athyreotic patients with a history of thyroid cancer is a straightforward clinical problem that needs to take into account the form of TH used, the timing of the blood tests to assess TSH concentrations, and other factors that affect the absorption and/or biologic availability of this important hormone. Here, TG is linked to thyroid gland carcinoma.